Brief: Atyr Pharma Announces Expanded Access Program (Eap) For Efzo-Fit™ Clinical Trial Participants

aTyr Pharma

21/02/2024 14:21

aTyr Pharma Inc  LIFE.O :
    * ATYR PHARMA ANNOUNCES EXPANDED ACCESS PROGRAM (EAP) FOR
EFZO-FIT™ CLINICAL TRIAL PARTICIPANTS
    * ATYR PHARMA INC - PLANS TO INITIATE INDIVIDUAL PATIENT EAP
FOR
ITS LEAD THERAPEUTIC CANDIDATE, EFZOFITIMOD, FOR PATIENTS WITH
PULMONARY SARCOIDOSIS
    * ATYR PHARMA INC - BY IMPLEMENTING EAP, COMPANY DOES NOT
ANTICIPATE ANY RISK TO ITS EFZOFITIMOD DRUG SUPPLY
    * ATYR PHARMA INC - BY IMPLEMENTING EAP, COMPANY DOES NOT
EXPECT A
SIGNIFICANT IMPACT TO ITS FINANCIAL RESOURCES

Source text for Eikon:  ID:nGNX9YWckv 
Further company coverage:  LIFE.O